AdaptHealth Corp. logo
AdaptHealth Corp. AHCO
$ 12.92 -1.22%

Annual report 2025
added 02-24-2026

report update icon

AdaptHealth Corp. Financial Statements 2011-2026 | AHCO

Annual Financial Statements AdaptHealth Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.2 B 1.43 B 1.36 B 2.13 B 2.39 B 2.01 B 941 M 310 M - - - - - - -

Shares

135 M 134 M 134 M 134 M 126 M 52.5 M 72.4 M 31.2 M - - - - - - -

Historical Prices

8.9 10.7 10.2 15.9 18.9 38.3 13.3 9.91 - - - - - - -

Net Income

-70.8 M 90.4 M -679 M 69.3 M 156 M -162 M -15 M 2.09 M -690 - - - - - -

Revenue

3.24 B 3.26 B 3.2 B 2.97 B 2.45 B 1.06 B 530 M - - - - - - - -

Cost of Revenue

2.64 B 2.58 B 2.58 B 2.39 B 2.01 B 899 M 441 M 293 M - - - - - - -

Gross Profit

- - - - - - 89.3 M - - - - - - - -

Operating Income

90.9 M 264 M -598 M 190 M 226 M 71.3 M 29.4 M 31.1 M - - - - - - -

Interest Expense

-274 K -2.79 M -29.6 M -253 K 95.2 M 41.4 M 39.3 M 7.45 M - - - - - - -

EBITDA

473 M 629 M -216 M 542 M 484 M 154 M 32.8 M -1.23 M -690 - - - - - -

Operating Expenses

- - - - - - 59.6 M 1.23 M 690 - - - - - -

General and Administrative Expenses

382 M 359 M 335 M 325 M 168 M 89.3 M 56.5 M 1.04 M 690 - - - - - -

All numbers in USD currency

Quarterly Income Statement AdaptHealth Corp.

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

135 M 135 M 135 M 135 M 134 M 133 M 133 M 133 M 135 M 134 M 135 M 134 M 134 M 134 M 134 M 134 M 132 M 130 M 111 M - 57.4 M 44.5 M 42 M - 21.7 M 21.7 M 13.9 M 7.2 M 7.26 M 7.2 M 7.2 M 7.19 M 7.19 M 7.19 M 7.19 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

24.5 M 14.7 M -7.21 M - 22.9 M 19.4 M -2.13 M - -454 M 14 M 15.7 M - 16.1 M 14 M 42.2 M - 58.1 M 80.1 M -3.64 M - -51 M 4.47 M -34.6 M - -3.69 M -2.08 M -5.8 M - 518 K 690 K 220 K - - - -693 - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

820 M 800 M 778 M - 806 M 806 M 792 M - 804 M 793 M 745 M - 756 M 728 M 706 M - 653 M 617 M 482 M - 284 M 232 M 1.06 B - 136 M 124 M 119 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

658 M 646 M 657 M - 644 M 637 M 635 M - 693 M 673 M 655 M - 647 M 610 M 597 M - 530 M 491 M 397 M - 241 M 198 M 168 M - 115 M 102 M 100 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

61.7 M 79.3 M 23.2 M - 63.5 M 52 M 50.5 M - -461 M 54.3 M 26.2 M - 52.9 M 59.2 M 51.6 M - 75.7 M 65.4 M 15.4 M - 13.3 M 15.6 M 8.22 M - 8.72 M 14.9 M 5.35 M - -445 K -234 K -72.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - - - 1.76 M -5.1 M - -3.32 M -2.08 M 32 M - 28.5 M 25.6 M 24.8 M - 24.3 M 23.1 M 22.2 M - 12.4 M 7.48 M 7.94 M - 10.8 M 14.6 M 6.26 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

154 M 166 M 118 M - 149 M 138 M 143 M - -371 M 144 M 120 M - 135 M 129 M 129 M - 257 M 176 M 62.6 M - 68.4 M 50.7 M 25 M - 53.8 M 43.1 M 20.3 M - -445 K -234 K -72.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

90.1 M 97.4 M 86.9 M - 87.3 M 99.4 M 89 M - 45.2 M 50.1 M 47.5 M - 40.7 M 42.5 M 41.4 M - 33 M 42.9 M 56.6 M - 26.3 M 17.1 M 14.3 M - 12.1 M 6.34 M 13.1 M - 391 K 163 K 50.7 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements AdaptHealth Corp. AHCO
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting AdaptHealth Corp. plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Electromed Electromed
ELMD
$ 25.3 0.8 % $ 214 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.32 0.3 % $ 124 M franceFrance
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 10.45 1.06 % $ 296 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.63 -1.29 % $ 39.2 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.01 1.52 % $ 1.22 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.06 2.43 % $ 18 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 14.68 0.27 % $ 344 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.46 -9.45 % $ 944 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 58.91 -0.02 % $ 3.21 B britainBritain
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Globus Medical Globus Medical
GMED
$ 89.55 1.99 % $ 12.1 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 10.23 0.2 % $ 366 M usaUSA
PAVmed PAVmed
PAVM
$ 8.54 -4.32 % $ 5.73 M usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 168.16 5.07 % $ 11.8 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 37.38 3.95 % $ 1.16 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 53.3 -0.21 % $ 1.57 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 87.37 4.42 % $ 3.03 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.07 4.02 % $ 5.74 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 81.79 0.7 % $ 47.8 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 316.83 0.54 % $ 121 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 22.39 -0.49 % $ 512 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.89 3.5 % $ 41.8 M usaUSA
LENSAR LENSAR
LNSR
$ 5.39 - $ 64.5 M usaUSA
TransMedics Group TransMedics Group
TMDX
$ 98.3 -0.27 % $ 3.34 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 18.53 2.04 % $ 1.26 B usaUSA